The U.S. Food and Drug Administration (FDA) has issued draft guidance meant to help developers of human gene therapies involving genome editing bring treatments to patients more efficiently, including those with rare and life-threatening diseases. Some recommendations also may apply to other cell and gene therapy products,…
Discussion
One of the greatest lessons my wife, Judy, and I have learned through raising our daughter, Rylae-Ann, is that there is a big difference between helping a child succeed and teaching a child to be helpless. Our daughter was born with aromatic l-amino acid decarboxylase (AADC) deficiency,…
Discussion
When our daughter, Rylae-Ann, was diagnosed with aromatic l-amino acid decarboxylase (AADC) deficiency at just 8 months old, the future felt uncertain. AADC deficiency is a rare genetic disorder that affects the body’s ability to produce important neurotransmitters such as dopamine and serotonin. The result can be…
Aromatic l-amino acid decarboxylase (AADC) deficiency is a genetic and neurometabolic disease that affects the nervous system. Learn more about the disease here.
AADC deficiency can affect many aspects of a person’s life, including mobility, breathing, sleeping, and eating. Learn more here about different ways to manage the condition, adapt, and handle everyday tasks.
There is not yet a cure for AADC deficiency, but there are approved treatments that can help manage the condition, as well as experimental treatments in the pipeline. Learn more about treating the disease here.
Get regular updates to your inbox.
